Skip to results
Modify your search
NARROW
1-20 of 72
Authors: Bridget Griffiths
Journal Article
P159 The clinical and immunological phenotype of male systemic lupus erythematosus in a large tertiary UK centre
Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.196, https://doi.org/10.1093/rheumatology/keaf142.196
Published: 28 April 2025
Journal Article
P136 Use of vasodilators in the management of severe Raynaud’s in patients with systemic sclerosis and the impact of the NHSE clinical commissioning policy
Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.176, https://doi.org/10.1093/rheumatology/keaf142.176
Published: 28 April 2025
Journal Article
P021 Experience of belimumab for the treatment of systemic lupus erythematosus in Newcastle Upon Tyne hospitals
Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.063, https://doi.org/10.1093/rheumatology/keaf142.063
Published: 28 April 2025
Journal Article
EDITOR'S CHOICE
The 2024 British Society for Rheumatology guideline for management of systemic sclerosis
Rheumatology, Volume 63, Issue 11, November 2024, Pages 2956–2975, https://doi.org/10.1093/rheumatology/keae394
Published: 11 September 2024
Journal Article
The 2024 British Society for Rheumatology guideline for management of systemic sclerosis—executive summary
Rheumatology, Volume 63, Issue 11, November 2024, Pages 2948–2955, https://doi.org/10.1093/rheumatology/keae390
Published: 11 September 2024
Journal Article
Relapse after cessation of weekly tocilizumab for giant cell arteritis: a multicentre service evaluation in England
Rheumatology, Volume 63, Issue 12, December 2024, Pages 3407–3414, https://doi.org/10.1093/rheumatology/kead604
Published: 11 November 2023
Journal Article
OA20 Differences in management approaches for lupus nephritis within the UK
Rheumatology, Volume 62, Issue Supplement_2, April 2023, kead104.020, https://doi.org/10.1093/rheumatology/kead104.020
Published: 24 April 2023
Journal Article
P037 The NIHR IMID Bioresource: a descriptive analysis of the first 5000 participants
Rheumatology, Volume 62, Issue Supplement_2, April 2023, kead104.078, https://doi.org/10.1093/rheumatology/kead104.078
Published: 24 April 2023
Journal Article
Quality standards for the care of people with giant cell arteritis in secondary care
Rheumatology, Volume 62, Issue 9, September 2023, Pages 3075–3083, https://doi.org/10.1093/rheumatology/kead025
Published: 24 January 2023
Journal Article
A Phase II randomized controlled trial of oral prednisolone in early diffuse cutaneous systemic sclerosis (PRedSS)
Rheumatology, Volume 62, Issue 9, September 2023, Pages 3133–3138, https://doi.org/10.1093/rheumatology/kead012
Published: 13 January 2023
Journal Article
COVID-19 antiviral therapy for non-hospitalized immunosuppressed patients with rheumatic diseases is feasible with positive outcomes
Rheumatology, Volume 62, Issue 6, June 2023, Pages e185–e187, https://doi.org/10.1093/rheumatology/keac705
Published: 19 December 2022
Journal Article
The BILAG-2004 index is associated with development of new damage in SLE
Rheumatology, Volume 62, Issue 2, February 2023, Pages 668–675, https://doi.org/10.1093/rheumatology/keac334
Published: 10 June 2022
Journal Article
P018 Are hospital-only specialist drugs being flagged in primary care records - a step closer toward patient safety
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.017, https://doi.org/10.1093/rheumatology/keac133.017
Published: 23 April 2022
Journal Article
P126 GCA Hospital Standards (GHOST) - making a map of specialised services for the care of giant cell arteritis across England
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.125, https://doi.org/10.1093/rheumatology/keac133.125
Published: 23 April 2022
Journal Article
P019 Audit of prostanoid use in severe Raynaud’s and adherence to treatment of digital ulcers in patients with SSc NHSE pathway: commissioning policy cost analysis and alternative therapeutic pathway proposed
Rheumatology, Volume 60, Issue Supplement_1, April 2021, keab247.018, https://doi.org/10.1093/rheumatology/keab247.018
Published: 26 April 2021
Journal Article
BSR guideline on the management of adults with systemic lupus erythematosus (SLE) 2018: baseline multi-centre audit in the UK
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1480–1490, https://doi.org/10.1093/rheumatology/keaa759
Published: 08 December 2020
Journal Article
Estimation of the burden of shielding among a cross-section of patients attending rheumatology clinics with SLE—data from the BSR audit of systemic lupus erythematosus
Rheumatology, Volume 60, Issue 3, March 2021, Pages 1474–1479, https://doi.org/10.1093/rheumatology/keaa620
Published: 14 October 2020
Includes: Multimedia
Journal Article
P15 An audit of the management of Behçet's disease in a tertiary referral centre against guidelines from EULAR and the National Centres of Excellence
Rheumatology, Volume 59, Issue Supplement_2, April 2020, keaa111.014, https://doi.org/10.1093/rheumatology/keaa111.014
Published: 20 April 2020
Journal Article
P39 Treatment of scleromyxedema with intravenous immunoglobulin
Rheumatology, Volume 59, Issue Supplement_2, April 2020, keaa111.038, https://doi.org/10.1093/rheumatology/keaa111.038
Published: 20 April 2020
Journal Article
P182 Prevalence and mortality of ANCA-associated vasculitis in England
Rheumatology, Volume 59, Issue Supplement_2, April 2020, keaa111.177, https://doi.org/10.1093/rheumatology/keaa111.177
Published: 20 April 2020
